Allelic origin of the abnormal prion protein isoform in familial prion diseases

S G Chen1, P Parchi, P Brown

  • 1Division of Neuropathology, Institute of Pathology, Case Western Reserve University, Cleveland, Ohio 44106, USA.

Nature Medicine
|September 1, 1997
PubMed

Insights

Prion diseases involve abnormal prion protein (PrP). This study shows mutant PrP causes PrP(res) in fatal familial insomnia and CJD178, while insertional mutations can involve wild-type PrP, explaining disease diversity.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Prion diseases are characterized by abnormal prion protein (PrP(res)), which is detergent-insoluble and protease-resistant.
  • Understanding the source of PrP(res) is crucial for elucidating disease mechanisms and heterogeneity.

Purpose of the Study:

  • To investigate the allelic origin of PrP(res) in individuals with specific prion protein gene mutations.
  • To determine whether wild-type or mutant prion protein contributes to PrP(res) formation in different familial prion disease subtypes.

Main Methods:

  • Analysis of brain tissue from subjects heterozygous for D178N mutation (linked to FFI and CJD178) and insertional mutations.
  • Assessing detergent insolubility and protease resistance of prion protein isoforms.

Main Results:

  • In FFI and CJD178, only mutant prion protein (PrP) was detergent-insoluble and protease-resistant, indicating PrP(res) exclusively from the mutant allele.
  • In contrast, a CJD subtype with insertional mutations showed both wild-type and mutant PrP becoming detergent-insoluble and protease-resistant.

Conclusions:

  • The allelic origin of PrP(res) formation is mutation-dependent.
  • Wild-type prion protein can participate in PrP(res) formation in certain familial prion diseases, contributing to phenotypic variability.

Related Concept Videos

Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...